Market Leads & Opportunities
Pipeline Framework: Specialised – Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
A pipeline has been launched for Specialised – Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema.The contract start Date is 01 July 2018. Approach to market date is 01 March 2018.Hereditary Angioedema.This is a potential opportunity from the government, and the pipeline gives advance notice of an opportunity that might be offered by the public sector in the future – allowing potential suppliers to plan accordingly. When a public sector organisation publishes a pipeline notice, it does not necessarily mean that an opportunity will be offered in the future.For more information contact: Commercial Medicines Unit – NHS England, 2nd Floor, Rutland House, Runcorn, WA7 2ES, England. Email: alison.greenwood3@nhs.net.
More Market Leads
- Committee to decide on more than 100 homes in Somerset
26 Feb 25
Plans for more than 100 homes in Somerset will go before committee today (25 February). - Funding for Argyll and Bute housing projects
26 Feb 25
The UK Government has committed to delivering a package of support from the CRP to Argyll and Bute Council totalling £20.34 million. - Lead developer sought for city centre redevelopment
26 Feb 25
Hull City Council says it has taken a step forward on its redevelopment of the former BHS building in the city centre.
- In association with::
